| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $201.6M | — | +27.8% |
| Cost of Revenue | $53.3M | — | +10.6% |
| Gross Profit | $148.3M | — | +35.4% |
| R&D Expense | $105.7M | — | +55.7% |
| SG&A Expense | $45.6M | — | +158.9% |
| Operating Income | -$108.7M | — | -139.7% |
| Income Tax | $3.1M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $205.8M | -52.4% | — |
| Short-term Investments | $897.3M | +23.7% | — |
| Accounts Receivable | $136.1M | -14.0% | — |
| Inventory | $5.2M | +6.6% | — |
| Current Assets | $1.37B | -5.4% | — |
| Total Assets | $1.69B |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$53.9M | — | -310.7% |
| Capital Expenditures | $2.2M | — | -70.9% |
| Investing Cash Flow | -$177.2M | — | -923.5% |
| Financing Cash Flow | $3.5M | — | -26.8% |
| Free Cash Flow | -$56.1M | — | -408.4% |
| +24.5% |
| Net Income | -$116.5M | — | -47.0% |
| EPS (Basic) | -$0.29 | — | +61.8% |
| EPS (Diluted) | -$0.29 | — | +61.8% |
| -4.6% |
| — |
| Current Liabilities | $632.3M | -7.2% | — |
| Total Liabilities | $1.52B | -3.9% | — |
| Stockholders' Equity | $175.5M | -9.8% | +133.3% |